Why Is Potaba So Hard to Find? [Explained for 2026]

If your doctor prescribed Potaba (potassium aminobenzoate) and you've been calling around to pharmacies with no luck, you're not alone. This medication is one of the more challenging prescriptions to fill in 2026 — not because of an official FDA shortage, but because of how the drug market works for niche, low-volume medications. Here's a plain-English explanation of why Potaba is hard to find and what your options are.

What Is Potaba and Why Is It Prescribed?

Potaba is the brand name for potassium aminobenzoate, a compound derived from the vitamin B complex. It is classified as an antifibrotic agent, meaning it works to reduce abnormal fibrous tissue buildup in the body. Physicians prescribe it for fibrotic conditions including Peyronie's disease, scleroderma, dermatomyositis, morphea, and pemphigus.

Despite being on the market for decades, Potaba remains a niche drug. It treats relatively rare conditions, its dosing regimen (up to 12 grams per day in divided doses) requires patients to take multiple capsules with every meal, and newer treatment options — especially for Peyronie's disease — have displaced it in many clinical guidelines. That niche status is the root cause of its availability problems.

Is Potaba in an Official FDA Shortage?

As of 2026, Potaba does not appear on the FDA's official Drug Shortage Database. That means the drug is technically being manufactured and distributed — the issue is not a manufacturing failure or raw-material crisis. However, "not in shortage" does not mean "easy to fill." Many major retail chains simply do not keep Potaba in stock because patient demand in any given zip code is too low to justify the inventory cost.

Think of it like trying to find a very specific imported ingredient at a grocery store. The item exists in the supply chain, but most stores don't bother stocking it. You have to search specifically for stores that carry it — or order it.

Why Don't Most Pharmacies Stock Potaba?

There are several practical reasons why Potaba sits on the shelf of few pharmacies:

Low prescription volume. The conditions it treats — particularly Peyronie's disease and systemic sclerosis — are not common diagnoses. Most individual pharmacies may fill only a handful of Potaba prescriptions per year.

High pill burden per patient. Because the standard adult dose is 12 grams per day, patients need a very large number of 500 mg capsules each month — making the product bulky and costly to stock.

Limited generic competition. While generic potassium aminobenzoate is available, fewer manufacturers produce it compared to blockbuster generics. This means fewer distribution points nationwide.

Guideline displacement. The AUA (American Urological Association) and EAU do not recommend Potaba as first-line therapy for Peyronie's disease. As clinical guidelines have shifted toward Xiaflex (collagenase clostridium histolyticum) injections, prescriptions for Potaba have declined further.

What Happens When a Pharmacy Doesn't Have It?

When a pharmacy doesn't have Potaba in stock, you generally have two options: wait for a special order (which can take 2–7 business days) or transfer your prescription to a pharmacy that already stocks it. The challenge is that most patients don't know which pharmacies stock it — and calling 10 pharmacies one by one is exhausting.

This is exactly the problem that medfinder was built to solve. Instead of spending hours on hold, you provide your medication information and location, and medfinder calls local pharmacies on your behalf to find out which ones can fill your Potaba prescription right now. Results are texted directly to you.

Specialty and Compounding Pharmacies: An Alternative Route

If local retail pharmacies cannot source Potaba, specialty pharmacies and compounding pharmacies are worth considering. Compounding pharmacies can prepare potassium aminobenzoate in customized doses or forms — including powders mixed into drinks — which may also be more comfortable for patients who struggle with swallowing large numbers of capsules. Always confirm with your prescriber before switching to a compounded preparation.

Will the Potaba Availability Situation Improve?

In the short term, the availability picture for Potaba is unlikely to change dramatically. The drug's market is small and its clinical role has narrowed as newer antifibrotic therapies have emerged. However, patients who need Potaba and work with a knowledgeable pharmacist — or use a service like medfinder — can still get it filled. It just requires more legwork than a typical prescription.

What You Can Do Right Now

Ask your prescribing doctor if they have a preferred pharmacy that reliably stocks Potaba.

Try independent and specialty pharmacies first — they often carry niche medications that chain pharmacies skip.

Use medfinder to have pharmacies called on your behalf — saving you hours of frustrating hold time.

Ask about a 2–3 day special order if your regular pharmacy doesn't have it on the shelf.

Discuss with your doctor whether alternatives like Xiaflex or pentoxifylline are appropriate for your condition if Potaba is consistently unavailable.

For a step-by-step guide on locating Potaba near you, see our article How to Find Potaba in Stock Near You.

If you are considering alternatives, read Alternatives to Potaba If You Can't Fill Your Prescription for a comparison of other options your doctor may consider.